Ingelmo-Torres M - Search Results

1

Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.

Carrasco R, Ingelmo-Torres M, Gómez A, Trullas R, Roldán FL, Ajami T, Moreno D, Rodríguez-Carunchio L, Alcaraz A, Izquierdo L, Mengual L. Carrasco R, et al. Among authors: ingelmo torres m. Int J Mol Sci. 2022 Oct 3;23(19):11732. doi: 10.3390/ijms231911732. Int J Mol Sci. 2022. PMID: 36233035 Free PMC article.

2

Molecular characterization of upper urinary tract tumours.

Izquierdo L, Mengual L, Gazquez C, Ingelmo-Torres M, Alcaraz A. Izquierdo L, et al. BJU Int. 2010 Sep;106(6):868-72. doi: 10.1111/j.1464-410X.2009.09135.x. Epub 2009 Dec 14. BJU Int. 2010. PMID: 20015323

3

Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.

Mengual L, Burset M, Ribal MJ, Ars E, Marín-Aguilera M, Fernández M, Ingelmo-Torres M, Villavicencio H, Alcaraz A. Mengual L, et al. Clin Cancer Res. 2010 May 1;16(9):2624-33. doi: 10.1158/1078-0432.CCR-09-3373. Epub 2010 Apr 20. Clin Cancer Res. 2010. PMID: 20406841

4

Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.

Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ, Alcaraz A. Mengual L, et al. Int J Cancer. 2013 Dec 1;133(11):2631-41. doi: 10.1002/ijc.28274. Epub 2013 Jun 14. Int J Cancer. 2013. PMID: 23686449 Free article.

5

Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models.

Mengual L, Ribal MJ, Lozano JJ, Ingelmo-Torres M, Burset M, Fernández PL, Alcaraz A. Mengual L, et al. J Urol. 2014 Jan;191(1):261-9. doi: 10.1016/j.juro.2013.06.083. Epub 2013 Jul 2. J Urol. 2014. PMID: 23831312

6

Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.

Izquierdo L, Ingelmo-Torres M, Mallofré C, Lozano JJ, Verhasselt-Crinquette M, Leroy X, Colin P, Comperat E, Roupret M, Alcaraz A, Mengual L. Izquierdo L, et al. BJU Int. 2014 May;113(5):813-21. doi: 10.1111/bju.12551. BJU Int. 2014. PMID: 24180461 Free article. Review.

7

Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers.

Mengual L, Ars E, Lozano JJ, Burset M, Izquierdo L, Ingelmo-Torres M, Gaya JM, Algaba F, Villavicencio H, Ribal MJ, Alcaraz A. Mengual L, et al. Actas Urol Esp. 2014 Apr;38(3):143-9. doi: 10.1016/j.acuro.2013.07.012. Epub 2013 Oct 25. Actas Urol Esp. 2014. PMID: 24206626 English, Spanish.

8

Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.

Ribal MJ, Mengual L, Lozano JJ, Ingelmo-Torres M, Palou J, Rodríguez-Faba O, Witjes JA, Van der Heijden AG, Medina R, Conde JM, Marberger M, Schmidbauer J, Fernández PL, Alcaraz A. Ribal MJ, et al. Eur J Cancer. 2016 Feb;54:131-138. doi: 10.1016/j.ejca.2015.11.003. Epub 2016 Jan 4. Eur J Cancer. 2016. PMID: 26761785

9

Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.

Mengual L, Lozano JJ, Ingelmo-Torres M, Izquierdo L, Musquera M, Ribal MJ, Alcaraz A. Mengual L, et al. BMC Cancer. 2016 Feb 9;16:76. doi: 10.1186/s12885-016-2127-2. BMC Cancer. 2016. PMID: 26856686 Free PMC article.

10

A five-gene expression signature to predict progression in T1G3 bladder cancer.

van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. van der Heijden AG, et al. Eur J Cancer. 2016 Sep;64:127-36. doi: 10.1016/j.ejca.2016.06.003. Epub 2016 Jul 11. Eur J Cancer. 2016. PMID: 27414486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page